Jack-of-all-trades Elon Musk just announced a new development effort intended to address the COVID-19 outbreak.
The exec says Tesla is working to produce a molecule printer in conjunction with German vaccine maker CureVac.
Musk calls the printers “RNA microfactories” that can produce vaccines and other mRNA-based therapies by inputting a recipe.
CureVac is backed by the Bill & Melinda Gates Foundation and, according to Reuters, is a “pioneer” in messenger RNA.
This approach differs from traditional vaccine development and allows researchers to use a biochemical process that doesn’t require living cells.
CureVac has been working with Tesla’s German operation to develop the printer.
The company also has a new site in the works that could eventually produce billions of doses of a vaccine.